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Background and Purpose: The vasomotor role of K2P potassium channels during
early postnatal development has never been investigated. We tested the hypothesis
that TASK‐1 channel (K2P family member) contribution to arterial vascular tone and
BP is higher in the early postnatal period than in adulthood.
Experimental Approach: We studied 10‐ to 15‐day‐old (“young”) and 2‐ to 3‐month‐
old (“adult”) male rats performing digital PCR (dPCR) (using endothelium‐intact
saphenous arteries), isometric myography, sharp microelectrode technique, quantita-
tive PCR (qPCR) and Western blotting (using endothelium‐denuded saphenous
arteries), and arterial pressure measurements under urethane anaesthesia.
Key Results: We found mRNA of Kcnk1–Kcnk7, Kcnk12, and Kcnk13 genes to be
expressed in rat saphenous artery, and Kcnk3 (TASK‐1) and Kcnk6 (TWIK‐2) were
most abundant in both age groups. The TASK‐1 channel blocker AVE1231
(1 μmol·L−1) prominently depolarized arterial smooth muscle and increased basal tone
level and contractile responses to methoxamine of arteries from young rats but had
almost no effect in adult rats. The level of TASK‐1 mRNA and protein expression was
higher in arteries from young compared with adult rats. Importantly, intravenous
administration of AVE1231 (4 mg·kg−1) had no effect on mean arterial pressure in
adult rats but prominently raised it in young rats.
Conclusion and Implications: We showed that TASK‐1 channels are important for
negative feedback regulation of vasocontraction in young but not adult rats. The
influence of TASK‐1 channels most likely contributes to low BP level at perinatal age.
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Abbreviations: BKCa, potassium channel, calcium‐activated large conductance subfamily M α, member 1; BP, blood pressure; dPCR, digital PCR; FAM, carboxyfluorescein; HR, heart rate; K2P,
two‐pore‐domain potassium channel; Kir, inwardly rectifying potassium channel; Kv, voltage‐gated potassium channel; MAP, mean arterial pressure; pD2, the negative logarithm of EC50; qPCR,
quantitative PCR; RIN, RNA integrity number; TASK‐1, potassium channel, two‐pore‐domain subfamily K, member 3; TBSt, tris‐buffered saline with 0.1% Tween 20; TWIK‐2, potassium channel,
two‐pore‐domain subfamily K, member 6.
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1 | INTRODUCTION
Adaptive changes in the blood supply of organs are a hallmark of
their growth and maturation (Štulcová, 1977). The vascular system
of the immature organism is characterized by a number of
structural and functional features, including, but not limited to, low
arterial pressure and greatly altered mechanisms of arterial tone
regulation (D. K. Gaynullina, Schubert, & Tarasova, 2019;
D. Gaynullina et al., 2013; Longo & Goyal, 2013; Mochalov
et al., 2018; Sofronova et al., 2016). Interestingly, a few studies
addressed the role of potassium channels in tone regulation of the
systemic vasculature during the early postnatal period. Thus, in the
immature period, BKCa channel blockade was ineffective regarding
tone regulation in rat basilar arteries (Gollasch et al., 1998), and
BKCa and Kv channel blockade produced only very small effects in
sheep middle cerebral arteries (Teng, Nauli, Brayden, &
Pearce, 2002), in contrast to later developmental stages. In rat
aorta, the effects of BKCa channel blockade also increased with
maturation, but the anticontractile influence of Kv channels was
higher in the neonatal period (Gomez, Ghisdal, & Morel, 2000).
Recently, we showed that in rat saphenous arteries in the early
postnatal period, the negative feedback regulation of
vasocontraction by BKCa channels was small, but the influence of
Kv1, Kir, and Kv7 channels was quite pronounced compared with
adult animals (Shvetsova, Gaynullina, Tarasova, & Schubert, 2019).
Thus, these data suggest that the contribution of potassium
channels to arterial tone regulation in the early postnatal period
varies depending on the vascular bed and/or channel type and,
therefore, cannot be predicted for channels not studied yet.
There is one potassium channel family, the K2P channels, whose
role in arterial tone regulation has been studied with comparatively
low intensity so far. Research over the last years has changed the
image of these channels from being simply leak channels to regulatory
channels having important roles in the control of cell excitability
(Renigunta, Schlichthörl, & Daut, 2015). Several members of the K2P
channel family have been shown to be expressed differentially in
various arteries (Gurney & Manoury, 2009). Most published studies
have been focused on TASK‐1 channels expressed in the majority of
the arteries investigated so far (Gurney & Manoury, 2009). This
channel was suggested to mediate changes in arterial tone induced by
pH alterations (Gardener et al., 2004) or hypoxia (Nagaraj et al., 2013;
Olschewski et al., 2006) in rabbit, rat, and human arteries. Moreover,
TASK‐1 channels have been proposed to be involved in human
pulmonary arterial hypertension (Antigny et al., 2016; Ma et al., 2013).
However, the contribution of TASK‐1 channels to the regulation of
vascular tone during early postnatal development has never been
addressed.
We tested the hypothesis that TASK‐1 channel contribution to
arterial vascular tone and BP is higher in the early postnatal period
than in adulthood. To evaluate the functional impact of TASK‐1
channels, we used AVE1231, which was initially described as a Kv1.5
channel blocker, but then demonstrated higher affinity for TASK‐1
channels (Kiper et al., 2015). To provide evidence for the specificity of
the effect of AVE1231 on TASK‐1 channels in relation to its possible
effects on Kv1.5 channels, we used DPO‐1, a specific Kv1 channel




Male Wistar rats aged 10 to 15 days (“young” in the following text)
and 2 to 3 months (“adult” in the following text) were used in this
study (obtained from Janvier, France, or the Institute of General
Pathology and Pathophysiology, Russia). Rats were killed under CO2
anaesthesia by decapitation. Animal studies are reported in compli-
ance with the ARRIVE guidelines (Percie du Sert et al., 2020) and with
the recommendations made by the British Journal of Pharmacology
(Lilley et al., 2020). Approval for the use of laboratory animals and all
procedures used in this study was granted by German and Russian
institutional committees on animal welfare (I‐17/17 and 93‐g, respec-
tively). Rats have been used for research on potassium channel func-
tion in early postnatal ontogenesis in many studies (Belevych, Beck,
Tammaro, Poston, & Smirnov, 2002; Gollasch et al., 1998; Shvetsova
et al., 2019). Since the male body is not subjected to cyclical hormonal
changes, we decided to employ a commonly used approach, namely,
to explore a novel physiological mechanism only in males. The animals
What is already known
• TASK-1 channels are expressed in arteries of the pulmo-
nary and systemic circulation.
• TASK-1 channel blockade by AVE1231 increases contrac-
tile responses in pulmonary arteries.
What this study adds
• TASK-1 channel expression is higher in arteries of 1- to
2-week-old compared with adult rats.
• TASK-1 channels contribute to arterial vascular tone and
the setting of the BP level in the early postnatal period.
What is the clinical significance
• The pathogenesis of cardiovascular diseases in neonates
can be associated withTASK-1 channel dysfunction.
• Potential vasopressor actions of TASK-1 channel blockers
should be considered in the recently suggested TASK-1
channel-targeted treatment of cardiac arrhythmia.
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were provided with food and water ad libitum and housed in a room
with a controlled temperature and a 12‐h light–dark cycle.
2.2 | Wire myograph experiments
The saphenous artery, a muscle‐type artery of the cutaneous
circulation, was chosen as the main object for the present study. The
arteries were carefully cleaned from surrounding tissue, cut into
2‐mm‐long segments, and mounted in a wire myograph (410A or
620M, DMT A/S, Denmark) to measure isometric force. Right after
mounting, the endothelium was gently denuded using a rat whisker.
These procedures were performed in a solution containing (mmol·L−1):
NaCl 145; KCl 4.5; CaCl2 0.1; MgSO4 1.0; NaH2PO4 1.2; EDTA 0.025;
and HEPES 5.0 (pH = 7.4).
During the subsequent experiments, arterial segments were kept
in a solution containing (mmol·L−1): NaCl 120; NaHСO3 26; KCl 4.5;
CaCl2 1.6; MgSO4 1.0; NaH2PO4 1.2; D‐glucose 5.5; EDTA 0.025; and
HEPES 5.0. The myograph chambers were heated to 37°C and
continuously bubbled with 5% CO2 in O2 to maintain pH at 7.4. Data
were recorded at 10 Hz using an analogue‐to‐digital converter
(E14‐140М, L‐CARD, Russia) and the PowerGraph 3.3 software
(DISoft, Russia) or the PowerLab 4/30 system (ADInstruments, USA)
and the LabChart software (ADInstruments, USA). Each arterial
segment was stretched to 0.9d100 (90% of the inner diameter it would
have at a transmural pressure of 100 mmHg), corresponding to
maximum active force development (Mulvany & Halpern, 1977;
Shvetsova et al., 2019).
At the beginning of each experiment, the following substances
activating contractile and relaxing pathways were applied
successively: (i) noradrenaline (10 μmol·L−1); (ii) methoxamine (α1‐
adrenoceptor agonist, 1 μmol·L−1) and, on top after 5 min, ACh
(10 μmol·L−1)—to confirm successful endothelium removal by the
absence of a relaxation response; and (iii) methoxamine (10 μmol·L−1).
The experimental protocol included two sequential
concentration–response relationships to methoxamine (concentration
range from 0.01 to 100 μmol·L−1). The first relationship was started
20 min after the end of the activation procedure. Thereafter, one
arterial segment was incubated for 20 min with a potassium channel
blocker (AVE1231, DPO‐1, or their combination) and the other one—
with an equivalent volume of the solvent (time control). Then the
second concentration–response relationship was obtained (for details,
see Figure 2).
To calculate active force values at each methoxamine concentra-
tion, the force value at the fully relaxed state was subtracted from all
recorded values. All active force values obtained during the second
concentration–response relationship (which are shown in Figure 3a–f)
were expressed as the percentage of the maximum active force devel-
oped during the respective first concentration–response relationship.
Presentation of data in percentage allows to eliminate variability due
to differences in the size of different vessels. To estimate the initial
sensitivity of arteries to methoxamine, individual concentration–
response relationships were fitted to a sigmoidal dose–response
(variable slope) equation using GraphPad Prism 7.0 (La Jolla, CA, USA,
RRID:SCR_002798) to obtain pD2 (the negative logarithm of EC50).
2.3 | Membrane potential measurements
Smooth muscle membrane potential was measured simultaneously
with isometric force using the sharp microelectrode technique as
described in our previous study (Shvetsova et al., 2019). Briefly,
saphenous arteries were isolated, denuded of the endothelium, and
mounted in a wire myograph (Model 301, DMT A/S, Denmark). At the
beginning of each experiment, vessels were normalized (0.9d100
values were determined), then the activation procedure was
performed, and a single concentration–response relationship to
methoxamine was obtained (for details, see Section 2.2). To exclude
distortion of the electrode by gas bubbles during membrane potential
measurements, the experimental solution was heated to 37°C and
bubbled with 5% CO2 in O2 in a separate reservoir and then supplied
to the myograph chamber by a peristaltic pump (Julabo, Germany) at a
rate of 2 ml·min−1.
Microelectrodes were made of aluminosilicate glass, filled with
saturated KCl, and had resistances of 30 to 70 MΩ. The resistance of
the electrode was continuously monitored by applying subthreshold
electrical pulses (20‐mV amplitude and 25‐ms duration) at a frequency
of 1 Hz. Membrane potential recordings were accepted if they were
characterized by (i) a sharp drop of the potential on cell penetration;
(ii) a stable level of the membrane potential recording for at least 30 s;
(iii) a return to the zero‐potential level after electrode removal; and
(iv) a similar electrode resistance before and after the measurement.
Membrane potential and force were determined under five
different experimental conditions (Figure 4): (1) in the absence of any
substance (Baseline 1); (2) during a methoxamine‐induced contraction
adjusted to ~20% of maximum force (the appropriate concentration
of methoxamine was identified based on the concentration–response
relationship); (3) after washout of methoxamine (Baseline 2); (4) in the
presence of 1 μmol·L−1 of AVE1231 or DMSO (equivalent volume);
and (5) during methoxamine‐induced contraction (the same
methoxamine concentration as at Step 2) in the presence of AVE1231
or DMSO.
Active force values were calculated as the percentage of
the maximum force obtained during the concentration–response
relationship to methoxamine.
2.4 | Measurement of mRNA expression levels in
arterial tissue by digital PCR
Endothelium‐intact saphenous arteries were quickly isolated from
young and adult rats. The preparation procedure was carried out in
ice‐cooled solution (for composition, see Section 2.2.). After isolation,
arteries were frozen in liquid nitrogen and stored at −80°C until
further manipulations. Each sample included four arteries from two
young rats or one artery from an adult rat.
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Arteries were homogenized using the TissueLyser (Qiagen). Total
RNA was isolated with the miRNeasy Mini Kit (Qiagen) according to
the manufacturer's instructions including a DNase‐treatment step.
RNA concentration was measured using a Tecan Plate Reader. RNA
quality was determined with a Bioanalyzer (ZMF). Only samples with
high quality (RNA integrity number [RIN] >7.5) were used for further
measurements.
For cDNA synthesis, 1‐μg total RNA was used in a standard
protocol (SensiFAST™ cDNA Synthesis Kit; BioCat GmbH (RRID:
SCR_001440), Heidelberg, Germany). First, expression of the Kcnk1–
Kcnk7, Kcnk9, Kcnk10, Kcnk12, Kcnk13, Kcnk15, Kcnk16, and Kcnk18
genes was tested in two cDNA samples from each age group of rats
by quantitative PCR (qPCR) using commercial assays (TaqMan™ Gene
Expression Assay, Thermo Fisher Scientific GmbH, Dreieich,
Germany). Second, chip‐based digital PCR (dPCR; QuantStudio® 3D,
Thermo Fisher Scientific) was performed for absolute quantification
of mRNA copies per μl for the Kcnk genes detectable by qPCR. The
TaqMan assays for Kcnk1–Kcnk7, Kcnk12, and Kcnk13 were applied
to all cDNA samples. After cycling, the dPCR chips were scanned for
the carboxyfluorescein (FAM) signals, and the data were uploaded to
the QuantStudio 3D AnalysisSuite cloud software (https://apps.
thermofisher.com/quantstudio3d). Based on the fluorescence signals
and statistical correction using Poisson distribution, the software
enabled calculation of target copies per μl.
2.5 | Measurement of mRNA expression levels in
arterial tissue by qPCR
Saphenous arteries were isolated, carefully cleaned from surrounding
tissue, cut into 8‐mm‐long segments, and quickly mounted in an ice‐
cooled analogue of a wire myograph system, to remove the
endothelium using a rat whisker. Endothelium‐denuded arterial
segments were kept in RNA‐later solution (Qiagen) at −20°C pending
further procedures. Each sample included four arterial segments, each
from two young rats, or two arterial segments from one adult rat. RNA
was extracted using the ExtractRNA kit (Evrogen, Russia) according to
the manufacturer's instructions, processed with DNase I (Fermentas,
1,000 U·ml−1). RNA concentration was measured by a NanoDrop 1000
(Thermo Scientific, USA), and then all samples were adjusted to a
concentration of 70 ng·μl−1. Reverse transcription was performed using
the MMLV RT kit (Evrogen, Russia) according to the manufacturer's
manual. qPCRwas run in the RotorGene6000 using qPCRmix‐HS SYBR
(Evrogen, Russia).
Primers used in this study were synthesized by Evrogen and had
the following sequences: Kcnk3 (forward: TGTCCATGGCCAAC
ATGGT; reverse: GGAAGAAAGTCCAGCGCTCAT), Gapdh (forward:
CACCAGCATCACCCCATTT; reverse: CCATCAAGGACCCCTTCATT),
Rn18s (forward: CACGGGTGACGGGGAATCAG; reverse: CGGGTCG
GGAGTGGGTAATTTG), and Nos3 (forward: GGATTCTGGCAAG
ACCGATTAC; reverse: GGTGAGGACTTGTCCAAACACT). Primer
efficiency was identified using the LinRegPCR software (Ruijter
et al., 2009) and was in the range of 1.8–2.0. mRNA expression levels
were calculated as E−Ct, where E is the primer efficiency and Ct is the
cycle number on which product fluorescence rose above the threshold
level. These values were normalized to the geometric mean of the
expression values for two housekeeping genes (Gapdh and Rn18s),
detected in the same sample. To compareTASK‐1 expression between
two experimental groups, all values were expressed as the percentage
of the median value in the adult group. Successful endothelium removal
was confirmed by about 10‐fold drop of Nos3 mRNA content in
endothelium‐denuded versus endothelium‐intact samples (Figure S1).
2.6 | Measurement of protein abundance in arterial
tissue by Western blotting
Four saphenous arteries from two young rats or two saphenous
arteries from one adult rat were used for one sample. The
endothelium was rapidly removed after isolation of the artery in the
same way as described for qPCR. Then arterial samples were quickly
frozen in liquid nitrogen and kept at −80°C till further analysis.
Samples were homogenized in ice‐cold SDS buffer (0.0625 mol·L−1 of
Tris–HCl (pH 6.8), 2.5% SDS, 10% water‐free glycerine, 2.47% DTT,
and 0.002% bromophenol blue) supplemented with protease
inhibitors (aprotinin 50 mg·ml−1, leupeptin 100 mg·ml−1, and pepstatin
30 mg·ml−1), centrifuged at 16,900 g for 5 min; the supernatant was
kept at −20°С till further analysis. Proteins were separated by
SDS‐PAGE and transferred to nitrocellulose membranes (Santa Cruz,
USA) using the Trans‐Blot Turbo transfer system (Bio‐Rad). The trans-
fer was visualized with Ponceau S staining, which was further used as
loading control (Romero‐Calvo et al., 2010). Thereafter the piece of
membrane (at the level of the TASK‐1 channel—approx. 40 kDa) was
cut out in order to save the antibodies against TASK‐1 channels. This
part of the membrane was blocked with 5% nonfat milk (AppliChem,
Germany) in TBS (20 mmol·L−1 of Tris–HCl, pH 7.6; 150 mmol·L−1 of
NaCl) with 0.1% Tween 20 (TBSt). Then it was incubated overnight
with rabbit polyclonal IgG antibodies against TASK‐1 channels
(Antigny et al., 2016) (Abcam Cat# ab49433, RRID:AB_881079, 1:800
in TBSt with 5% BSA). The next day, the membrane was incubated
with goat anti‐rabbit IgG secondary antibodies (Cell Signaling
Technology Cat# 7074, RRID:AB_2099233, 1:10,000 in 5% milk in
TBSt) for 1 h and visualized with SuperSignal West Dura Substrate
(Thermo Scientific) using ChemiDoc (Bio‐Rad). Western blotting
experiments were analysed using the Image Lab software (Bio‐Rad).
TheTASK‐1 protein was normalized to loading control (determined by
Ponceau S staining) in each sample, and then the median ratio of the
adult group was taken as 100%. The Immuno‐related procedures used
comply with the recommendations made by the British Journal of
Pharmacology (Alexander et al., 2018).
2.7 | BP measurement
Haemodynamic measurements were performed in urethane‐
anaesthetized rats (1.2 g·kg−1, i.p.). Urethane is widely used as
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anaesthesia in acute experiments with a terminal point, and it
provides long‐term (1 h or more) and stable anaesthesia in rats,
including 1‐week‐old pups (Mochalov et al., 2018). Other types of
anaesthesia do not match these requirements and may exert
undesirable side effects. For example, isoflurane was shown to
activate some potassium channels, including several K2P family
members (Patel et al., 1999). The use of ketamine in laboratory
practice is prohibited in the Russian Federation (Governmental Decree
N681 from June 30, 1998). Successful anaesthesia throughout the
experiment was indicated as the absence of pupil and flexion reflexes
with a potentially painful effect on the foot.
For arterial BP measurements, a polyethylene catheter
(PE5‐PE50) was inserted into the left carotid artery. For drug
injections, two catheters (PE5‐PE50) were inserted in parallel into the
left jugular vein. Body temperature was maintained at 36–37°C with a
heating blanket throughout the experiment. Arterial BP was
continuously sampled at 1,000 Hz using a BLPR2 transducer (World
Precision Instruments, USA) and an USB‐6211 analog‐to‐digital
converter (National Instruments, USA). Data recording and processing
were performed using a custom‐made software written in LabVIEW
2011 (National Instruments, RRID:SCR_014325). To avoid clotting,
the arterial catheter was continuously flushed with heparinized saline
(50 U·ml−1) using a Syringe pump (Model 341, SAGE Instruments,
USA); the infusion rate was 0.2 ml·h−1 (for adult rats) or 0.08 ml·h−1
(for young rats).
During the initial 10–15 min, arterial pressure and heart rate
(HR) were allowed to stabilize. Then the ganglionic blocker
chlorisondamine (2.5 mg·kg−1, i.v.) was injected through a venous
catheter, and a 10‐ to 15‐min‐long baseline recording was obtained.
Then AVE1231 (4 mg·kg−1, i.v.) or its solvent DMSO (0.5 ml·kg−1) was
injected through the second venous catheter, and the recording was
continued for more than 15 min.
The BP signal was processed beat‐to‐beat to estimate mean
arterial pressure (MAP) and HR. Then MAP and HR were averaged in
1.5‐ to 2‐min‐long intervals: (i) before chlorisondamine administration;
(ii) before AVE1231 or DMSO administration; and (iii) at the peak
response to AVE1231 or the corresponding time period after
administration of DMSO.
2.8 | Drugs
Noradrenaline, ACh, methoxamine (all dissolved in H2O), and all salts
(American Chemical Society [ACS] grade, for analysis) were obtained
from Sigma. DPO‐1 (dissolved in DMSO) and chlorisondamine
(dissolved in 0.9% NaCl) were obtained from Tocris. AVE1231
(dissolved in DMSO) was a kind gift of Sanofi.
2.9 | Data and statistical analysis
The data and statistical analysis comply with the recommendations of
the British Journal of Pharmacology on experimental design and
analysis in pharmacology (Curtis et al., 2018). Treatment of arterial
segments with certain substances within each experimental group
was randomized. Blinding of the operator was not feasible because
vessel responses observed by the operator to manage the experiment
permitted inferences about the treatment. However, data analysis
was performed semi‐blinded by an independent analyst.
The number of experiments was selected during experimental
design based on considerations not to employ an unnecessary amount
of animals (3R principles) and to get evidence for an effect of
reasonable size in both age groups. Based on the experience of
previous studies, the number of animals/tissue samples in each group
was at least 6, except for one sample in Figure S1 with n = 5. Our
previous experiments showed that haemodynamic and vasomotor
responses in young rats can be more variable; therefore, we planned
and performed more experiments in the young than in adult group,
and therefore, adult and young groups are not of equal size. The
group size is the number of independent values, and statistical
analysis was done using these independent values. Outliers were
included in data analysis and presentation.
Statistical analysis was performed using GraphPad Prism 7.0
(La Jolla, CA, USA, RRID:SCR_002798). The normality of the data
distribution was tested using the Shapiro–Wilk test. Data are
presented as mean and SD (if data distribution was normal) or as
median and the interquartile range (if data distribution was different
from normal); n represents the number of animals (wire myograph,
membrane potential, and BP data) or tissue samples (mRNA and
protein contents).
Concentration–response relationships to methoxamine between
two groups were compared using repeated measures ANOVA.
Statistical analyses of values of vessel diameter, force, membrane
potential, mRNA contents, and protein contents were performed
using a two‐sided unpaired Student's t test or Mann–Whitney U test,
depending on the type of data distribution. Differences were
accepted as statistically significant if the P value was less than 0.05.
2.10 | Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to
corresponding entries in http://www.guidetopharmacology.org and
are permanently archived in the Concise Guide to PHARMACOLOGY
2019/20 (Alexander, Christopoulos, et al., 2019; Alexander, Mathie,
et al., 2019).
3 | RESULTS
3.1 | Expression pattern of K2P channels in
saphenous arteries of adult and young rats
At the first step of the study, we evaluated the abundance of different
K2P family members in arterial tissue on the mRNA level using dPCR.
In endothelium‐intact saphenous arteries of adult rats (n = 7), mRNA
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for Kcnk1–Kcnk7, Kcnk12, and Kcnk13 was expressed (Figure 1a).
Among them, mRNA for Kcnk3 and Kcnk6 was the most abundant
(Figure 1a). Next, we measured the mRNA expression of K2P family
members in endothelium‐intact saphenous arteries (n = 7) of young
rats. Similarly, mRNA for Kcnk1–Kcnk7, Kcnk12, and Kcnk13 was
expressed (Figure 1b); the highest expression level was found for
Kcnk3 and Kcnk6 (Figure 1b). mRNA for Kcnk9, Kcnk10, Kcnk15,
Kcnk16, and Kcnk18 was not detected in arterial samples from either
adult or young animals. The functionality of the qPCR assays for these
Kcnk genes was demonstrated by positive qPCR results from cDNA of
rat brain for all Kcnk genes except Kcnk18. The use of seven different
qPCR assays for different Kcnk18 regions confirmed the negative
result and indicated a very low or absent expression of Kcnk18 in rat
brain. Assuming functionality, the commercial TaqMan Kcnk18 qPCR
assay was used for expression analysis in the arterial samples.
3.2 | Effects of AVE1231 and DPO‐1 on arterial
contractile responses in adult and young rats
The next steps in our study were focused onTASK‐1 (Kcnk3) channels
since this channel (i) is one of the most abundant in saphenous
arteries in both age groups; (ii) is one of the most studied in the
circulatory system; and (iii) is one of the few K2P channels for which a
tool for functional studies is available (TASK‐1 channel blocker
AVE1231/A293) (Antigny et al., 2016; Kiper et al., 2015).
The inner normalized diameter (d100) of saphenous arteries was
625 ± 87 μm for adult (n = 10) and 271 ± 24 μm for young rats
(n = 16, P < 0.05, unpaired Student's t test). Maximum active wall ten-
sion was 8.3 ± 2.1 mN·mm−1 for adult (n = 10) and 2.1 ± 0.7 mN·mm−1
for young animals (n = 16, P < 0.05, unpaired Student's t test).
Importantly, the first concentration–response relationships to
methoxamine for endothelium‐denuded arterial segments further
treated with potassium channel blockers or solvent, respectively, were
not different within the same age group (Table 1).
Blockade of TASK‐1 channels with 1 μmol·L−1 of AVE1231 (Kiper
et al., 2015) did not change the level of basal tone and contractile
responses to methoxamine in arteries of adult rats (Figure 3a).
However, in arteries of young rats, 1 μmol·L−1 of AVE1231 caused
the development of a basal tone (about 30% of maximum force)
(Figures 2 and 3b). This effect was quite variable and sometimes was
accompanied by a small decline with time (Figure 2). The level of
active force developed by arteries of young rats during application of
methoxamine was also increased by TASK‐1 channel blockade with
F IGURE 1 mRNA expression of K2P members in endothelium‐intact saphenous arteries from adult (a, n = 7) and young (b, n = 7) rats. Kcnk1,
TWIK‐1; Kcnk2, TREK‐1; Kcnk3, TASK‐1; Kcnk4, TRAAK; Kcnk5, TASK‐2; Kcnk6, TWIK‐2; Kcnk7, TWIK‐3; Kcnk12, THIK‐2; Kcnk13, THIK‐1.
mRNA of Kcnk9 (TASK‐3), Kcnk10 (TREK‐2), Kcnk15 (TASK‐3), and Kcnk18 (TRESK‐2) was not detected. Data are presented as the median and
interquartile range
TABLE 1 pD2 and maximum active force values of the first concentration–response relationships to methoxamine (preceding the application
of either blocker or solvent) in different series of experiments in arteries from adult and young rats
Series of experiments
pD2 Maximum active force (mN)
Adult Young Adult Young
AVE1231 (n = 6, 9) 5.97 ± 0.14 5.69 ± 0.26 36 ± 7 8.3 ± 1.1
DPO‐1 (n = 6, 8) 6.00 ± 0.15 5.71 ± 0.27 37 ± 7 8.4 ± 2.3
DPO‐1 + AVE1231 (n = 6, 8) 5.99 ± 0.17 5.70 ± 0.23 35 ± 8 8.9 ± 1.7
Time‐control (n = 6, 9) 5.94 ± 0.26 5.71 ± 0.20 29 ± 10 8.6 ± 2.1
Note: Data are presented as mean ± SD.
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AVE1231 (Figures 2 and 3b). These data indicate that TASK‐1
channels are important for the regulation of arterial tone in young, but
not in adult animals.
Of note, AVE1231 was originally described as a Kv1.5 channel
blocker (Ehrlich, Ocholla, Ziemek, & Ru, 2008; Wirth et al., 2007).
Thus, its effect on vessels from young rats might be possibly
related to its effect on Kv1.5 channels. In order to test this
possibility, we performed additional control experiments using the
Kv1.5 channel blocker DPO‐1 (Fancher et al., 2015; Lagrutta
et al., 2006). DPO‐1 (1 μmol·L−1) did not alter basal tone and
contractile responses to methoxamine of arteries from adult
animals (Figure 3c). Further, AVE1231 in the presence of DPO‐1
slightly elevated basal tone and did not change the contractile
responses to methoxamine in arteries of adult animals (Figure 3e).
In arteries from young rats, DPO‐1 did not affect basal tone but
increased methoxamine‐induced contractions (Figure 3d). Impor-
tantly, AVE1231 in the presence of DPO‐1 strongly augmented
basal tone and contractions to methoxamine of arteries from young
animals (Figure 3f). These data show that the effects of AVE1231
in arteries of young rats remain after blockade of Kv1.5 channels
and, therefore, are considered to be predominantly associated with
its influence on TASK‐1 channels.
3.3 | Effects of AVE1231 on smooth muscle cell
membrane potential in adult and young rats
The resting membrane potential (Step 1 in Figure 4, combined data
for AVE1231 and time‐control experiments) was −65.0 ± 5.7 mV
(n = 14) and −67.0 ± 3.4 mV (n = 16) in endothelium‐denuded
saphenous arteries of adult and young animals respectively (P = 0.26,
unpaired Student's t test).
Importantly, the values of force and membrane potential at Step
1 as well as the methoxamine‐induced depolarization and increase in
active force (Step 2 in Figure 4; see Section 2 for detailed description)
did not differ between preparations further treated with AVE1231 or
solvent, respectively, within the same age group (Table 2). This setting
allowed us to estimate the effects of AVE1231 by comparing the
values at Steps 3–5 between AVE1231‐ and DMSO‐treated vessels
(these data are shown in Figure 5a–d).
AVE1231 did not change basal tone in arteries of adult rats
(Figure 5a) but induced smooth muscle depolarization (Figure 5c). In
arteries of adult animals, the values of active force and membrane
potential during methoxamine application were similar in the presence
of AVE1231 or solvent (Figure 5a,c). In contrast, in arteries of young
animals, AVE1231 induced strong basal tone (Figures 4 and 5b)
F IGURE 2 Recordings of contractile responses of two saphenous artery segments to methoxamine in a 12‐day‐old rat. The first
concentration–response relationships (left panels in a and b) are similar for the two arterial segments. Application of theTASK‐1 channel blocker
AVE1231 (1 μmol·L−1) causes an increase in basal tone and of the contractile responses to methoxamine (a), while incubation with an equivalent
volume of the solvent (5‐μl DMSO per 5‐ml myograph chamber) does not affect the level of basal tone and the contractile response (b). W,
washout
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associated with pronounced smooth muscle depolarization (Figures 4
and 5d). Importantly, the AVE1231‐induced depolarization (identified
as the difference between Step 4 and Step 3 in AVE1231‐treated
preparations; see Figure 4 and Section 2 for description) was consider-
ably larger for young rats (19.1 [16.6–26.5] mV, n = 10) compared with
adult animals (12.3 [5.7–15.4] mV, n = 7, P < 0.05, Mann–Whitney
U test). Further, in young rats, AVE1231 considerably increased
methoxamine‐induced contraction and led to higher depolarization
compared with time‐control preparations (Figures 4 and 5b,d). Taken
together, these data demonstrate that the stronger influence of
TASK‐1 channel blockade on basal tone and methoxamine‐induced
contractile responses in arteries of young rats compared with older
animals is associated with its higher impact on membrane potential.
3.4 | Comparison of TASK‐1 channel abundance in
endothelium‐denuded arteries of adult and young rats
In order to identify whether the observed stronger impact of TASK‐1
channels on smooth muscle contractile responses and depolarization
in the younger age group is associated with their higher abundance in
arterial smooth muscle, we estimated mRNA and protein contents of
TASK‐1 in endothelium‐denuded arteries of the two age groups.
Indeed, the relative expression level of the Kcnk3 gene in arterial
preparations was considerably higher in young compared with adult
animals (Figure 6a). Further, protein abundance of TASK‐1 channels
was larger in smooth muscle of young compared with adult animals
(Figure 6b). Thus, our results clearly demonstrate that the larger role
of TASK‐1 channels at the functional level in arteries of young rats is
associated with their higher expression level.
3.5 | Effects of AVE1231 on systemic cardiovascular
parameters in adult and young rats
To assess the role of TASK‐1 channels in the regulation of systemic
haemodynamics, we evaluated the effects of AVE1231 on MAP and
HR in anaesthetized rats. At the beginning of the experiment, MAP
was almost two times lower in young compared with adult animals;
F IGURE 3 Effects of AVE1231,
DPO‐1, and their combined effects on
the contractile responses to methoxamine
of arteries from two age groups. (a, b)
Concentration–response relationships to
methoxamine in the presence of solvent
(DMSO) or theTASK‐1 channel blocker
(AVE1231, 1 μmol·L−1) of arteries from
adult (a; n = 6, 6) and young rats (b; n = 9,
9), respectively. (c, d) Concentration–
response relationships to methoxamine in
the presence of solvent (DMSO) or the
Kv1 channel blocker (DPO‐1, 1 μmol·L−1)
of arteries from adult (c; n = 6, 6) and
young (d; n = 9, 8) rats, respectively. (e, f )
Concentration–response relationships to
methoxamine in the presence of Kv1
channel blocker only (DPO‐1, 1 μmol·L−1)
or the Kv1 channel blocker together with
TASK‐1 channel blocker (DPO‐
1 + AVE1231, both 1 μmol·L−1) of arteries
from adult (e; n = 6, 6) and young (f; n = 8,
8) rats, respectively. B.t., basal tone value
(active force before the first
concentration of methoxamine). Data are
presented as mean ± SD. *P < 0.05
between AVE1231 and DMSO or DPO‐
1 + AVE1231 and DPO‐1 application
(repeated measures ANOVA). $P < 0.05
between basal tone values of AVE1231
and DMSO or DPO‐1 + AVE1231 and
DPO‐1 application (unpaired Student's t
test)
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HR did not differ between the two age groups (Table S1). In order to
exclude the influence of the autonomic nervous system, the effects of
AVE1231 were studied after ganglionic blockade by chlorisondamine
(2.5 mg·kg−1). After ganglionic blockade, both MAP and HR values
were lower in young compared with adult rats (Table S1).
In each age group, some of the animals were further treated with
AVE1231 and others with the vehicle (DMSO). Importantly, no differ-
ences in baseline values of either MAP or HR were observed between
the two subgroups (further treated with AVE1231 or with DMSO)
within the same age group (Table S2). In adult rats, AVE1231 induced
a transient increase of MAP that was similar to the changes in
the DMSO‐treated subgroup (Figure 7a). In contrast, in young rats,
the AVE1231‐induced MAP increase was larger compared with the
DMSO‐treated subgroup (Figure 7b). The effect of AVE1231 on MAP
plateaued after 2–3 min. Noteworthy, HR levels after administration
of AVE1231 were not different compared with their levels in the
DMSO‐treated subgroups in both adult and young animals (Table S2).
Thus, TASK‐1 blockade increased the systemic BP level only in young
rats, and this effect was not associated with an altered HR.
4 | DISCUSSION
This study provides novel data on developmental alterations in the
functioning of TASK‐1 channels in arterial smooth muscle. We
showed that smooth muscle mRNA and protein content of TASK‐1
channels is higher in peripheral arteries from young compared with
adult rats. In accordance with this, TASK‐1 channels oppose
vasocontraction by counteracting arterial smooth muscle depolariza-
tion only at early postnatal age but not in adulthood. Moreover,
TASK‐1 channel blockade affected systemic BP in young but not
adult rats.
4.1 | TASK‐1 channels are highly abundant in rat
saphenous arteries
A number of studies have demonstrated expression of some K2P
channel members in cerebral (Bryan et al., 2006) as well as pulmonary
and mesenteric arteries (Gardener et al., 2004) of rats. To the best of
our knowledge, for the first time, we evaluated the expression pattern
of all known K2P channel family members in a rat artery, the saphe-
nous artery, using the dPCR approach. The advantage of dPCR is that
it enables to estimate the number of single mRNA molecules in tissue
samples regardless of primer efficiency. The latter allows the
quantitative comparison of the mRNA contents of different K2P
channel family members. The results of our screening demonstrate
that saphenous arteries of both adult and young rats contain a large
number of TWIK‐2 and TASK‐1 mRNA. Noteworthy, using dPCR, we
did not compare the content of K2P channel family members between
TABLE 2 Changes of force and membrane potential induced by methoxamine during the first application (Step 2 in Figure 4) in experiments
with either blocker (AVE1231) or vehicle (DMSO) application in arteries from adult and young rats
Parameter
Adult Young
Before AVE1231 (n = 7) Time‐control (n = 7) Before AVE1231 (n = 10) Time‐control (n = 6)
Change of force (% of maximum) 19.1 ± 14.6 14.8 ± 8.4 17.3 ± 9.9 18.2 ± 3.6
Change of membrane potential (mV) 24.0 ± 4.7 20.5 ± 6.3 20.0 ± 10.7 19.6 ± 12.7
Note: Data are presented as mean ± SD.
F IGURE 4 Traces of an experiment with
simultaneous registration of force and membrane
potential of a saphenous artery from a 12‐day‐
old‐rat. Membrane potential and force were
detected under five experimental conditions:
(1) in the absence of any blockers or agonists—
Baseline 1; (2) during methoxamine‐induced
contraction (about 20% of maximum force);
(3) after washout of methoxamine—Baseline 2;
(4) in the presence of AVE1231 (1 μmol·L−1); and
(5) in the presence of AVE1231 (1 μmol·L−1)
together with the same concentration of
methoxamine as at Step 2
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F IGURE 6 TASK‐1 channel abundance in endothelium‐denuded arteries of two age groups. (a) Relative expression levels of Kcnk3 pore‐
forming subunit mRNA in arteries from adult (n = 8) and young (n = 9) rats. Data are normalized to the geometric mean of Rn18s and Gapdh.
(b) Protein content of TASK‐1 pore‐forming subunit in arteries from adult (n = 7) and young (n = 6) rats. Data are normalized to loading control
(determined by Ponceau S staining). The median value of TASK‐1 mRNA or protein content in the adult group is taken as 100%. Data are
presented as the median and interquartile range. #P < 0.05 between adult and young animals (Mann–Whitney U test)
F IGURE 5 The effects of AVE1231 on force and membrane potential in arterial smooth muscle of two age groups. (a, b) The values of force
at baseline (Bl2, corresponds to Baseline 2 in Figure 4), solvent (DMSO) or TASK‐1 channel blocker (AVE1231, 1 μmol·L−1), and under the
combination of methoxamine (MX) and solvent (DMSO + MX) or AVE1231 (AVE1231 + MX) in saphenous arteries of adult (a; n = 7, 7) and young
rats (b; n = 6, 10), respectively. (c, d) The corresponding values of membrane potential in arteries of adult (c) and young (d) rats, respectively. Data
are presented as the median and interquartile range. #P < 0.05 between time‐control and AVE1231 application (Mann–Whitney U test)
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adult and young rats since the data for two age groups came from
two different experimental series.
4.2 | TASK‐1 channels are more abundant in smooth
muscle cells of young compared with adult rats
Since the TASK‐1 channel is one of the most abundant K2P channel
family member in the rat saphenous artery, developmental alterations
of TASK‐1 expression in rat saphenous arteries were evaluated using
standard qPCR and Western blot techniques. We showed for the first
time that the contents of TASK‐1 channel mRNA and protein are
higher in arteries of young rats compared with adult animals. Similarly,
previously, we demonstrated increased expression levels of Kv7.4
channels and its accessory KCNE4 subunit in arteries of 10‐ to
15‐day‐old rats (Shvetsova et al., 2019). These observations point to
alterations in the expression pattern of several potassium channels in
the developing vasculature. Noteworthy, all these studies were
performed on arteries with denuded endothelium, so that the
expression of the channel was determined mainly for arterial smooth
muscle cells of the two age groups.
4.3 | TASK‐1 channels are important for the
regulation of membrane potential and arterial tone in
arteries of young rats
The ability of K2P channels to conduct outward potassium currents in
a wide potential range suggests their important role in the regulation
of membrane potential and, therefore, vascular tone (Gurney &
Manoury, 2009). Indeed, a number of studies have demonstrated a
pronounced anticontractile influence of these channels in pulmonary
arteries of human and rat (Antigny et al., 2016; Gardener et al., 2004).
However, a functional role of TASK‐1 channels in pulmonary arteries
of mice was not observed (Manoury, Lamalle, Oliveira, Reid, &
Gurney, 2011; Murtaza et al., 2017). We also did not observe consid-
erable effects of AVE1231 on contractile responses in saphenous
arteries of adult rats, despite it caused small subthreshold depolariza-
tion of their smooth muscle. Similarly, in our previous experiments on
the saphenous artery of adult rats, the blockade of Kv7 or Kir
channels (by XE991 [3 μmol·L−1] or BaCl2 [30 μmol·L
−1], respectively)
depolarized arterial smooth muscle by about 7 mV, while it did not
induce the development of a basal tone (Shvetsova et al., 2019). In
addition, in experiments on rat small mesenteric and tail arteries, an
increase of the extracellular potassium concentration up to
20–25 mmol·L−1 induced depolarization of smooth muscle cells by
10–15 mV, which was not associated with the development of
contractile responses (Mulvany, Nilsson, & Flatman, 1982; Neild &
Kotecha, 1987). Therefore, during non‐receptor stimulation, arterial
smooth muscle starts to contract only from a certain threshold level
of membrane potential. Probably, 12‐mV smooth muscle depolariza-
tion induced by AVE1231 in arteries from adult rats was subthreshold
for the development of a contractile response.
In contrast, in young rats, blockade of TASK‐1 channels with
AVE1231 caused a strong smooth muscle depolarization, which was
sufficient for the development of contraction. Previously, we
demonstrated a higher contribution of Kir and especially Kv7 channels
in the regulation of membrane potential and vascular tone in arteries
from young compared with adult rats (Shvetsova et al., 2019). Our
new data suggest that TASK‐1 channels together with Kir and Kv7
channels play an important role in the negative feedback regulation of
vasocontraction in the period of early postnatal ontogenesis, but not
in adulthood.
To our knowledge, in this study, AVE1231 was used to study the
role of TASK‐1 channels in rat systemic arteries for the first time.
Previously, AVE1231 (A293) at the same concentration (1 μmol·L−1)
was shown to increase contractile responses of isolated rat pulmonary
arteries (Antigny et al., 2016). Of note, the IC50 of AVE1231 for
human TASK‐1 channels in Xenopus oocytes is 0.2 μmol·L−1, while its
IC50 against Kv1.5 is 43 times higher (Kiper et al., 2015). Thus, at the
concentration used, AVE1231 would block primarily and considerably
TASK‐1 channels but not Kv1.5 channels. This suggestion is
supported by our data showing additive effects of AVE1231
(1 μmol·L−1) and DPO‐1 (1 μmol·L−1) in arteries of young rats. Since
F IGURE 7 AVE1231 increases mean arterial
pressure (MAP) in young (b) but not adult
(a) animals. The change of MAP was calculated as
the difference between the peak MAP value after
intravenous administration of vehicle (DMSO,
0.5 ml·kg−1) or AVE1231 (4 mg·kg−1) and the
respective baseline value. The experiments were
performed under the condition of ganglionic
blockade (chlorisondamine, 2.5 mg·kg−1). Data are
presented as the median and interquartile range.
#P < 0.05 between DMSO and AVE1231
experiments (Mann–Whitney U test)
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the IC50 for DPO‐1 against Kv1.5 channels is less than 0.2 μmol·L
−1
(Lagrutta et al., 2006), 1 μmol·L−1 of DPO‐1 should block Kv1.5 chan-
nels to a large degree (in a specific manner) (Tsvetkov et al., 2016).
Thus, the large additional effect of 1 μmol·L−1 of AVE1231 is most
likely due to a block of TASK‐1 channels rather than a blockade of the
few remaining Kv1.5 channels after DPO‐1 blockade.
Therefore, TASK‐1 channels counteract arterial smooth muscle
depolarization and, thereby, reduce contractile responses of arterial
smooth muscle in young but not adult rats, in line with the greater
expression of TASK‐1 channels in smooth muscle of saphenous
arteries at the early postnatal period. Of note, TASK‐1 channels
limiting smooth muscle depolarization are most likely located primarily
in the smooth muscle cells of the vessel wall since the effects of
AVE1231 on basal tone and on contractile responses to methoxamine
were comparable in endothelium‐intact and endothelium‐denuded
arteries from young rats (Figure S2).
4.4 | TASK‐1 channels are important for arterial BP
control in young rats
To get further insight into the physiological role of TASK‐1 channels,
we compared the effects of AVE1231 on MAP in the two age groups
of rats. Of note, blood flow to the skin comprises up to 20% of the
cardiac output (Štulcová, 1977) and, thereby, is functionally relevant.
Therefore, functional alterations of skin feed (saphenous) arteries
could affect the BP level in young rats.
In our experiments, AVE1231 was dissolved in DMSO, which is
the most often used vehicle for hydrophobic substances. However,
DMSO may exert its own biological effects, which could confound the
effects of AVE1231 (Kelava, Cavar, & Culo, 2011; Sawada &
Sato, 1975). To distinguish between the effects of the blocker and the
vehicle, we compared the change of MAP at the same time points in
animal groups treated with AVE1231 and DMSO respectively.
In a previous study, Wirth et al. (2007) evaluated the in vivo
effects of AVE1231 in pigs and goats using a dose of 3 mg·kg−1. In
our experiments, we started from a dose of 1 mg·kg−1 and then
increased it in a stepwise manner to get an evident effect on BP at
least in one of the experimental groups. The minimum dose of
AVE1231, which affected BP, was 4 mg·kg−1. This is close to the dose
in the study by Wirth et al. (2007), especially taking into account the
differences in body surface area and metabolic rate between
pigs/goats and rats (Nair & Jacob, 2016; Reagan‐Shaw, Nihal, &
Ahmad, 2008).
The MAP level was almost two times lower in young rats
compared with adult animals, which is consistent with previously
published data (Mochalov et al., 2018). The intravenous administra-
tion of AVE1231 (4 mg·kg−1) increased MAP in young rats, but not
adult animals. Similarly, loss‐of‐function mutations in TASK‐1
channels did not change systemic arterial pressure in adult rats
(Lambert et al., 2019). Therefore, TASK‐1 channels have a
depressor effect at the systemic level only in the period of early
postnatal development.
It is important to note that our experiments were carried out
under conditions of ganglionic blockade. The use of ganglionic
blockade allowed us to exclude the influence of AVE1231 on the
activity of the autonomic nervous system and, therefore, to
evaluate its effects exclusively in the periphery. TASK‐1 channels
are abundant in rat brain, including the ventrolateral medulla
neurons, which are involved in the autonomic control of the
circulation (Kindler, Pietruck, Yost, Sampson, & Gray, 2000;
Washburn, Bayliss, & Guyenet, 2003). Of note, the expression of
TASK‐1 channels in the rat ventrolateral medulla is developmentally
regulated (Kanjhan, Anselme, Noakes, & Bellingham, 2004).
Therefore, in the absence of ganglionic blockade, AVE1231 would
affect the nervous control of the circulation, which is different in
adult and young rats because of the immaturity of the vasomotor
innervation in the younger group (Puzdrova et al., 2014).
We did not find differences in HR between AVE1231‐ and
DMSO‐treated groups of rats at either age. Previously, no
chronotropic effect of AVE1231 in a similar dose (3 mg·kg−1) was
observed in anaesthetized pigs as well (Wirth et al., 2007). Thus, we
suggest that in our experimental conditions, AVE1231 had no
prominent effect on heart function.
Taken together, our in vivo observations support the in vitro data
demonstrating a more prominent influence of TASK‐1 channels in
arteries from young compared with older rats. Based on our results,
we suggest that TASK‐1 channels are important regulators of vascular
tone and arterial pressure in the early postnatal period. Our BP
measurements point to the presence of a TASK‐1 channel‐dependent
control of vascular resistance not only in cutaneous but also in other
vascular regions.
5 | CONCLUSION
In conclusion, our novel findings demonstrate a pronounced negative
feedback regulation of vasocontraction by TASK‐1 channels in the
early postnatal period in rats. Taking into account the growing
incidence of primary hypertension in childhood (Flynn, 2018), it is
extremely important to identify all particular players regulating
vascular tone and BP in the immature organism. We suppose that a
large contribution of TASK‐1 channels together with Kir and Kv7
channels (Shvetsova et al., 2019) is important to reduce peripheral
vascular resistance and the BP level in the newborn organism to
protect the immature arteries from high transmural pressure and the
immature heart from high afterload. In addition, a pronounced
anticontractile role of TASK‐1 channels may contribute to an increase
in the blood supply to growing organs during early postnatal develop-
ment. It is known that the mechanisms regulating arterial smooth
muscle contraction shift from calcium independent to calcium depen-
dent during postnatal maturation (Akopov, Zhang, & Pearce, 1998a,
1998b; Mochalov et al., 2018; Puzdrova et al., 2014). Similarly, the
role of potassium channels regulated by calcium to a lesser extent
(TASK‐1, Kv7, and Kir) decreases, while the role of calcium‐dependent
BKCa channels increases during postnatal development (Shvetsova
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et al., 2019), which could be a hallmark of maturation of peripheral
arteries. The mechanism providing the postnatal decline in the contri-
bution of TASK‐1 channels to the regulation of vascular tone remains
elusive and could serve as a topic for future studies.
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